Registry of In Process and Executed VA CRADAs
To track CRADAs and to create an educational resource, the Technology Transfer Program (TTP) requires VA Medical Centers (VAMCs) or Non-Profit Corporations (NPCs) to register CT CRADAs through the TTP website.
Upon initiating negotiations, please go the website and fill out as much as possible of the form Blank CRADA Excel spreadsheet (76 KB, Excel) spreadsheet. Please send this completed (or semi-completed) Excel sheet for each CT CRADA to Noahline Stuart (noahline.stuart@va.gov).
The information provided will be integrated into two master registries. The first will be a spreadsheet titled "registry of CRADAs in process" (see below). After the CT CRADA is completed and executed, re-submit the Excel spreadsheet after adding the remaining information. The second registry will be titled "executed CRADAs" (see below) and will entail all currently executed CRADAs.
If negotiations terminate without executing a CRADA please notify Noahline Stuart and provide a brief explanation of termination. This information will also be integrated into the CRADA Registry (highlighted CRADAs have been executed) (727 KB, MS Excel)
Master CRADAs
VA has master template CRADAs where no additional legal or TTP review of the CRADA body is needed. A list of the approved master template CRADAs for Phase III&IV clinical trials are below. Please email Noahline Stuart (noahline.stuart@va.gov) for a copy. If a phase II with these companies is needed please contact Ken Levin (Ken.Levin@va.gov).
- Amgen
- Astellas
- Bristol-Myers Squibb
- Celgene
- Genentech
- GSK
- Merck
- Novartis
- OncoGenex
- Pfizer
- Roche
- Sanofi-Aventis
- Sucampo
-
Watson Pharmaceuticals
TTP has also completed negotiations on a master template CRADA with several other companies. The master template CRADAs are going through the concurrence process but are available for immediate single site use. Please email Ken Levin for a copy (Ken.Levin@va.gov).
- AstraZeneca
- Allegro Diagnostics
- Lilly & Lilly when Quintiles is the CRO
- Regenesis Biomedical, Inc.
- Takeda